Home23J0 • FRA
add
Promis Neurosciences Inc
Previous close
€0.50
Day range
€0.56 - €0.56
Year range
€0.47 - €1.96
Market cap
21.16M USD
Avg Volume
490.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | -1.82M | -210.46% |
Net income | -238.21K | 93.35% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.50M | 35.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.32M | 5.49% |
Total assets | 18.91M | 38.86% |
Total liabilities | 2.42M | -75.44% |
Total equity | 16.49M | — |
Shares outstanding | 32.69M | — |
Price to book | 1.00 | — |
Return on assets | -28.82% | — |
Return on capital | -52.66% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -238.21K | 93.35% |
Cash from operations | -8.72M | -131.89% |
Cash from investing | -693.00 | 48.63% |
Cash from financing | 470.00K | 192.05% |
Net change in cash | -8.25M | -93.10% |
Free cash flow | -4.00M | -33.49% |
About
Founded
2004
Headquarters
Website
Employees
8
